Bluejay Diagnostics, Inc. · NASDAQ:BJDX

Braeden Lichti reported a 3.65% stake in Bluejay Diagnostics, Inc. (Schedule 13D)

Event Mar 11, 2026 · Filed Mar 11, 2026

Braeden Lichti reported a 3.65% stake in Bluejay Diagnostics, Inc., 35,500 shares, with active intent on Mar 11, 2026. Filed Mar 11, 2026 (Schedule 13D).

Stake
3.65%
Shares
35,500
Intent
Active
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Northstrive Fund II LP1.13%11,000
Braeden Lichti3.65%35,500

Source

View original at SEC

Related